|
1. Biologie
|
|
|
|
1.4 Biologie - Technos
|
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
5.12.2 Immunothérapies - CAR-T, thérapies cellulaires
|
|
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
Update on EMA’s Brexit preparedness [EMA]
|
|
|
|
|
|
Temporary
suspension and scaling back of activities is currently scheduled to
last until 30 June 2019, but will be reviewed in April 2019, once the
Agency has completed its move to its temporary building in Amsterdam.
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.6 ESMO
|
|
|
|
|
|
|
5.6.11 ESMO- Rein
|
|
|
|
5.6.14 ESMO - Ovaire
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.6 Publications
|
|
|
|
6.8 Communication
|
|
|
|
6.9 Controverses
|
|
|
Was cancer scientist fired for challenging lab chief over authorship? [Science]
|
|
|
|
|
|
Xie’s
dismissal comes against a backdrop of increased scrutiny of the power
structure in science. It also shines a light on the perennially fraught
issue of how credit for authorship is designated in a hugely competitive
environment in which prominent placement as an author propels young
careers and sustains established ones.
|
|
|
|
|
|